PocketHealth is a technology company.
PocketHealth is a platform that allows patients to access and share their medical imaging records online, providing convenience and control over their health information.
PocketHealth has raised $49.0M across 2 funding rounds.
PocketHealth has raised $49.0M in total across 2 funding rounds.
PocketHealth has raised $49.0M in total across 2 funding rounds.
PocketHealth's investors include Advent Life Sciences, Draper Associates, F-Prime Capital Partners, Global Ventures, Maverick Capital, Questa Capital, Curtis Chambers.
PocketHealth is a Toronto-based healthcare technology company founded in 2016 that provides an AI-powered platform for medical image exchange, patient access to records, and non-clinical workflow automation.[1][2][3] It serves patients, healthcare providers, and hospitals by digitizing imaging sharing—eliminating CDs—and automating tasks like referral intake, scheduling, and communications, allowing teams to focus on care.[1][2][4] The platform solves key problems in healthcare interoperability, such as manual data handling and patient leakage, with tools like AI-driven image readers and report simplifiers; it now supports over 2 million patients and 900+ hospitals/clinics across North America, following a $33M Series B in 2024 to fuel AI enhancements and expansion.[2][8]
Growth momentum is strong: from initial patient imaging access, it has evolved into agentic AI orchestration, reducing costs (e.g., 95% non-labor savings for one hospital) and boosting engagement, with recent features like Physician Hub and free patient access driving adoption at systems like UC Health.[2][5][10]
PocketHealth was co-founded in 2016 by brothers Rishi Nayyar (CEO) and Harsh Nayyar (CTO), Canadian entrepreneurs motivated by a personal healthcare frustration.[1][2] Harsh's 2016 tennis injury required carrying a CT scan CD between providers, highlighting the inefficiency of outdated physical media for sharing medical images—this sparked the idea to digitize and streamline the process.[2]
Starting as PocketSix Technology, the company gained early traction by enabling patient access to imaging reports, then expanded to provider tools amid rising demand for interoperability.[2][3] Pivotal moments include serving 775 sites by 2024, a $33M Series B for AI and scaling (doubling headcount from 110), and partnerships like UC Health, which ditched legacy tech for PocketHealth's platform.[2][5] The founders' vision of impactful tech has humanized healthcare data access, evolving from image sharing to full AI workflow automation.[1]
PocketHealth rides the healthcare AI and interoperability wave, addressing data silos amid rising imaging volumes and patient demands for control—exacerbated by antiquated CDs and manual workflows.[2][4] Timing aligns with FHIR standards adoption, post-pandemic digital shifts, and AI advancements like multimodal models (language/vision/voice), enabling "agentic" automation that bridges patients, providers, and systems.[1][6]
Market forces favor it: 87% of leaders prioritize patient satisfaction; regulations push secure data flow; cost pressures reward efficiency gains.[4][5] It influences the ecosystem by setting patient-empowerment benchmarks—e.g., free access reduces barriers—in a $100B+ digital health market, competing with Sharecare/Redox while pioneering visual AI for diagnostics.[3][6]
PocketHealth is poised to dominate AI-driven imaging and workflows, expanding Image Reader to more modalities, rolling out Physician Hub widely, and penetrating U.S. markets post-Series B.[2][5][6] Trends like universal segmentation AI and connected care will accelerate growth, potentially tripling users as hospitals ditch legacy tech. Its influence may evolve from niche exchanger to ecosystem orchestrator, empowering patients as in the origin injury story—turning personal pain into scalable, frictionless health journeys.[1][2]
PocketHealth has raised $49.0M across 2 funding rounds. Most recently, it raised $33.0M Series B in March 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2024 | $33.0M Series B | Advent Life Sciences, Draper Associates, F-Prime Capital Partners, Global Ventures, Maverick Capital, Questa Capital, Curtis Chambers | |
| Mar 1, 2022 | $16.0M Series A | Advent Life Sciences, Draper Associates, F-Prime Capital Partners, Global Ventures, Maverick Capital, Questa Capital, Curtis Chambers |